1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.75%
Positive revenue growth while 4997.T is negative. John Neff might see a notable competitive edge here.
65.99%
Positive gross profit growth while 4997.T is negative. John Neff would see a clear operational edge over the competitor.
52.93%
Positive EBIT growth while 4997.T is negative. John Neff might see a substantial edge in operational management.
59.53%
Positive operating income growth while 4997.T is negative. John Neff might view this as a competitive edge in operations.
39.28%
Positive net income growth while 4997.T is negative. John Neff might see a big relative performance advantage.
39.31%
Positive EPS growth while 4997.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
39.31%
Positive diluted EPS growth while 4997.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-95.18%
Negative 10Y revenue/share CAGR while 4997.T stands at 49.51%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-56.35%
Negative 5Y CAGR while 4997.T stands at 41.65%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-48.31%
Negative 3Y CAGR while 4997.T stands at 35.82%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
97.04%
Positive 10Y CAGR while 4997.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-100.43%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-1159.55%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
218.02%
5Y equity/share CAGR above 1.5x 4997.T's 57.62%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
12.04%
Below 50% of 4997.T's 43.98%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.17%
Our AR growth while 4997.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
30.87%
We show growth while 4997.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
18.56%
Positive asset growth while 4997.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-1.04%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
63.62%
We have some new debt while 4997.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-41.99%
We cut SG&A while 4997.T invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.